Prognostic significance of tumor budding in patients with pancreatic invasive ductal carcinoma who received neoadjuvant therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prognostic significance of tumor budding in patients with pancreatic invasive ductal carcinoma who received neoadjuvant therapy

Published:2024-01 Issue:1 Volume:10 Page:e23928
ISSN:2405-8440
Container-title:Heliyon
language:en
Short-container-title:Heliyon

Author:

Ibuki Emi^ORCID,Kadota Kyuichi,Kimura Nachino^ORCID,Ishikawa Ryou^ORCID,Oshima Minoru,Okano Keiichi,Haba Reiji

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference44 articles.

1. Cancer statistics, 2022;Siegel;CA A Cancer J. Clin.,2022

2. Clinical and pathological features of five-year survivors after pancreatectomy for pancreatic adenocarcinoma;Kimura;World J. Surg. Oncol.,2014

3. Is a preoperative assessment of the early recurrence of pancreatic cancer possible after complete surgical resection?;La Torre;Gut and liver,2014

4. The predictors and patterns of the early recurrence of pancreatic ductal adenocarcinoma after pancreatectomy: the influence of pre- and post- operative adjuvant therapy;Suto;BMC Surg.,2019

5. TWIST1 is a prognostic factor for neoadjuvant chemotherapy for patients with resectable pancreatic cancer: a preliminary study;Fujiwara;Surg. Today,2023

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlation between tumor budding and the long-term follow-up outcomes after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma;Surgical Endoscopy;2024-08-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP